Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Top Smart Score Stocks

STOCKS

Research Tools

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Economic Indicators

Economic Indicators Center

Inflation Rate

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Popular

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

News

Portfolio

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Student Loan Calculator

401k Retirement Calculator

Education

About Us

Working with TipRanks

Molecular Partners (MOLN)

NASDAQ:MOLN

MOLN

Molecular Partners

RESEARCH TOOLS

Top Smart Score Stocks

Stock Screener

reports

Holding MOLN?

Track your performance easily

Link Broker

Molecular Partners (MOLN) Income Statement

27 Followers

Molecular Partners Income Statement

Last quarter (Q4 2023), Molecular Partners's total revenue was CHF―, a decrease of -100.00% from the same quarter last year. In Q4, Molecular Partners's net income was CHF―. See Molecular Partners’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	CHF 14.09M	CHF 7.04M	CHF 189.60M	CHF 9.75M	CHF 9.34M	CHF 20.38M
Cost of Revenue	-	-	CHF -72.99M	CHF -73.17M	-	-
Gross Profit	-	CHF 7.04M	CHF 189.54M	CHF 9.33M	-	-
Operating Expense	CHF 35.07M	CHF 67.29M	CHF 73.61M	CHF 73.17M	CHF 67.67M	CHF 57.04M
Operating Income	CHF -20.99M	CHF -60.26M	CHF 115.93M	CHF -63.84M	CHF -58.33M	CHF -36.66M
Net Non Operating Interest Income Expense	CHF 53.00K	CHF 4.23M	CHF 1.86M	CHF 191.00K	CHF 63.00K	CHF 1.50M
Other Income Expense	CHF 3.09M	CHF 853.00K	CHF -5.38M	CHF -424.00K	CHF -4.51M	CHF -1.11M
Pretax Income	CHF -17.84M	CHF -61.98M	CHF 117.85M	CHF -63.78M	CHF -62.77M	CHF -36.27M
Tax Provision	-	-	-	CHF 2.00K	CHF -11.00K	CHF 17.00K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	CHF -17.84M	CHF -61.98M	CHF 123.17M	CHF -55.78M	CHF -62.76M	CHF -36.29M
Basic EPS	-	CHF -1.89	CHF 3.63	CHF -2.06	-	-
Diluted EPS	-	CHF -1.89	CHF 3.54	CHF -2.06	-	-
Basic Average Shares	-	CHF 32.77M	CHF 32.47M	CHF 31.01M	-	-
Diluted Average Shares	-	CHF 32.77M	CHF 34.79M	-	-	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	CHF 35.07M	CHF 67.29M	CHF 619.00K	-	CHF 67.67M	CHF 57.04M
Net Income From Continuing And Discontinued Operation	CHF -17.84M	CHF -61.98M	CHF 123.17M	CHF -55.78M	CHF -62.76M	CHF -36.29M
Normalized Income	CHF -20.93M	-	-	-	CHF -58.25M	CHF -35.38M
Interest Expense	CHF 350.00K	-	-	-	CHF 295.00K	CHF 64.00K
EBIT	CHF -17.49M	-	CHF 117.85M	CHF -63.78M	CHF -62.48M	CHF -36.21M
EBITDA	CHF -16.33M	-	CHF 120.24M	CHF -61.22M	CHF -59.59M	CHF -33.74M

Currency in CHF

Molecular Partners Earnings and Revenue History

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing